Scholar Rock Holding Corp (SRRK)
14.53
+0.57
(+4.08%)
USD |
NASDAQ |
Apr 26, 16:00
14.53
0.00 (0.00%)
After-Hours: 20:00
Scholar Rock Shareholders Equity (Quarterly): 225.22M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 225.22M |
| September 30, 2023 | 167.66M |
| June 30, 2023 | 202.50M |
| March 31, 2023 | 228.65M |
| December 31, 2022 | 260.24M |
| September 30, 2022 | 293.26M |
| June 30, 2022 | 329.51M |
| March 31, 2022 | 171.32M |
| December 31, 2021 | 172.07M |
| September 30, 2021 | 187.26M |
| June 30, 2021 | 216.66M |
| March 31, 2021 | 240.54M |
| December 31, 2020 | 260.77M |
| Date | Value |
|---|---|
| September 30, 2020 | 62.98M |
| June 30, 2020 | 82.17M |
| March 31, 2020 | 98.65M |
| December 31, 2019 | 112.90M |
| September 30, 2019 | 121.79M |
| June 30, 2019 | 128.96M |
| March 31, 2019 | 97.52M |
| December 31, 2018 | 106.62M |
| September 30, 2018 | 102.34M |
| June 30, 2018 | 111.61M |
| March 31, 2018 | 47.36M |
| December 31, 2017 | -53.52M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
62.98M
Minimum
Sep 2020
329.51M
Maximum
Jun 2022
187.53M
Average
187.26M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 25.97B |
| Ocular Therapeutix Inc | 91.13M |
| Alpine Immune Sciences Inc | 327.94M |
| Keros Therapeutics Inc | 332.21M |
| X4 Pharmaceuticals Inc | 51.10M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 311.04M |
| Total Liabilities (Quarterly) | 85.82M |